Shares of Westwater Resources plunged 7.6% to $0.57 on August 11 as investors digested a second-quarter loss that widened even as the company celebrated a federal loan approval — raising a blunt question about whether Washington's backing can bridge a yawning construction shortfall.
• Losses Keep Growing With Zero Revenue in Sight. Westwater reported a Q2 net loss of $4.3 million, up from $3.9 million a year earlier, bringing its six-month loss to $9.0 million versus $6.5 million in the prior-year period.
The company has never recorded revenue from its graphite operations , and management expects continued cash losses until the Kellyton plant is complete — which itself depends on securing more funding. For shareholders, every quarter without production means more cash consumed with nothing coming back in.
• A $25 Million Loan Covers Barely a Fifth of What's Needed. The Export-Import Bank approved a $25 million direct loan to support the Kellyton Graphite Plant in Alabama , providing non-dilutive capital — meaning it doesn't force the company to issue new shares — for construction and equipment. But the math is sobering. The loan represents just 21.7% of the roughly $115 million in remaining Phase I costs.
Even if the full amount is drawn, roughly $90 million would still be needed. And closing remains subject to documentation and customary conditions, so the money hasn't actually arrived yet.
• Both Major Customers Have Walked Away. SK On terminated its procurement agreement on March 31, 2026, following FCA's earlier termination of its offtake agreement in November 2025. Those were two of Westwater's three signed buyers. Without binding purchase commitments, lenders and investors have less assurance the plant's output will generate returns. The exits, combined with the funding gap, increase commercialization risk until new contracts are secured.
• Dilution Risk Looms Over a Sub-Dollar Stock. Cash stood at $38.2 million as of June 30 , down from $41.5 million three months prior. The company has 128.6 million shares outstanding with 400 million authorized, sold no shares via its at-the-market program last quarter, but retains $70.6 million of ATM capacity and $26.2 million under its equity credit line. That's nearly $97 million in potential share sales that would shrink existing owners' stakes. The 88% rally on the EXIM headline already reversed sharply — a pattern that suggests traders are treating each piece of good news as a selling opportunity until the funding gap genuinely closes.